The first Amedisys trade was made in Q3 2014.
Since then Paul Tudor Jones II bought shares ten more times and sold shares on eleven occasions. The investor completely sold their stake between Q2 2024 and Q3 2024.
Avg closing price
Price range
Sold -10.7 Thousand shares
Q3 2024
Avg closing price
$97.57
Price range
$96.51
-
$98.45
Sold 93.8% shares (-162 Thousand shares)
Q2 2024
Avg closing price
$92.79
Price range
$90.40
-
$96.77
Increased shares by 473.4% (+142 Thousand shares)
Q1 2024
Avg closing price
$93.71
Price range
$92.15
-
$95.24
New holding (+30 Thousand shares)
Q4 2023
Avg closing price
$93.40
Price range
$91.15
-
$95.90
Sold -27.7 Thousand shares
Q2 2023
Avg closing price
$82.04
Price range
$73.99
-
$92.60
New holding (+27.7 Thousand shares)
Q1 2023
Avg closing price
$86.52
Price range
$69.79
-
$100.33
Sold -1.57 Thousand shares
Q1 2022
Avg closing price
$149.40
Price range
$124.79
-
$178.09
New holding (+1.57 Thousand shares)
Q4 2021
Avg closing price
$160.71
Price range
$136.32
-
$184.41
Sold -10.2 Thousand shares
Q3 2019
Avg closing price
$130.18
Price range
$117.97
-
$137.89
Sold 76.3% shares (-32.9 Thousand shares)
Q2 2019
Avg closing price
$118.67
Price range
$108.08
-
$129.67
Increased shares by 39.7% (+12.3 Thousand shares)
Q1 2019
Avg closing price
$125.51
Price range
$110.76
-
$138.73
New holding (+30.9 Thousand shares)
Q4 2018
Avg closing price
$117.86
Price range
$98.20
-
$140.23
Sold -12.8 Thousand shares
Q3 2018
Avg closing price
$110.43
Price range
$87.74
-
$125.01
Increased shares by 49.1% (+4.22 Thousand shares)
Q2 2018